551 related articles for article (PubMed ID: 26836051)
21. IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy.
Ruiz B; Serrano P; Moreno C
J Investig Allergol Clin Immunol; 2016; 26(6):355-361. PubMed ID: 27996941
[TBL] [Abstract][Full Text] [Related]
22. Sensitization to Hymenoptera venom marker allergens: Prevalence, predisposing factors, and clinical implications.
Stoevesandt J; Hosp C; Kerstan A; Trautmann A
Clin Exp Allergy; 2018 Dec; 48(12):1735-1743. PubMed ID: 30044028
[TBL] [Abstract][Full Text] [Related]
23. Simplification of intradermal skin testing in Hymenoptera venom allergic children.
Cichocka-Jarosz E; Stobiecki M; Brzyski P; Rogatko I; Nittner-Marszalska M; Sztefko K; Czarnobilska E; Lis G; Nowak-Węgrzyn A
Ann Allergy Asthma Immunol; 2017 Mar; 118(3):326-332. PubMed ID: 27986410
[TBL] [Abstract][Full Text] [Related]
24. Improved sensitivity to venom specific-immunoglobulin E by spiking with the allergen component in Japanese patients suspected of Hymenoptera venom allergy.
Yoshida N; Hirata H; Watanabe M; Sugiyama K; Arima M; Fukushima Y; Ishii Y
Allergol Int; 2015 Jul; 64(3):248-52. PubMed ID: 26117256
[TBL] [Abstract][Full Text] [Related]
25. An increase in serum tryptase even below 11.4 ng/mL may indicate a mast cell-mediated hypersensitivity reaction: a prospective study in Hymenoptera venom allergic patients.
Borer-Reinhold M; Haeberli G; Bitzenhofer M; Jandus P; Hausmann O; Fricker M; Helbling A; Müller U
Clin Exp Allergy; 2011 Dec; 41(12):1777-83. PubMed ID: 22092437
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxis.
González-de-Olano D; Alvarez-Twose I; Morgado JM; Esteban López MI; Vega Castro A; Díaz de Durana MD; Sánchez-Muñoz L; Matito A; de la Hoz Caballer B; Sanz ML; Orfao A; Escribano L
Cytometry B Clin Cytom; 2011 May; 80(3):167-75. PubMed ID: 21520404
[TBL] [Abstract][Full Text] [Related]
27. Hymenoptera Allergy and Mast Cell Activation Syndromes.
Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690
[TBL] [Abstract][Full Text] [Related]
28. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.
Ruëff F; Vos B; Oude Elberink J; Bender A; Chatelain R; Dugas-Breit S; Horny HP; Küchenhoff H; Linhardt A; Mastnik S; Sotlar K; Stretz E; Vollrath R; Przybilla B; Flaig M
Clin Exp Allergy; 2014; 44(5):736-46. PubMed ID: 24447114
[TBL] [Abstract][Full Text] [Related]
29. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
Gawlik R; Glück J; Jawor B; Rogala B
Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
[TBL] [Abstract][Full Text] [Related]
30. New developments in the diagnosis and treatment of hymenoptera venom allergy.
Müller UR
Int Arch Allergy Immunol; 2001 Apr; 124(4):447-53. PubMed ID: 11340327
[TBL] [Abstract][Full Text] [Related]
31. Serum tryptase concentrations in beekeepers with and without Hymenoptera venom allergy.
Carballada F; Alonso M; Vizcaino L; Coutinho V; Núñez R; Vidal C; Boquete M; González-Quintela A
J Investig Allergol Clin Immunol; 2013; 23(1):30-6. PubMed ID: 23653971
[TBL] [Abstract][Full Text] [Related]
32. Clinical aspects of hymenoptera venom allergy and venom immunotherapy.
Bilò MB; Tontini C; Martini M; Corsi A; Agolini S; Antonicelli L
Eur Ann Allergy Clin Immunol; 2019 Nov; 51(6):244-258. PubMed ID: 31594296
[TBL] [Abstract][Full Text] [Related]
33. How much specific is the association between hymenoptera venom allergy and mastocytosis?
Bonadonna P; Zanotti R; Pagani M; Caruso B; Perbellini O; Colarossi S; Olivieri E; Dama A; Schiappoli M; Senna G; Antico A; Passalacqua G
Allergy; 2009 Sep; 64(9):1379-82. PubMed ID: 19627274
[TBL] [Abstract][Full Text] [Related]
34. Hymenoptera venom allergy.
Przybilla B; Ruëff F
J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase.
Potier A; Lavigne C; Chappard D; Verret JL; Chevailler A; Nicolie B; Drouet M
Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252
[TBL] [Abstract][Full Text] [Related]
36. The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study.
Sturm GJ; Böhm E; Trummer M; Weiglhofer I; Heinemann A; Aberer W
Allergy; 2004 Oct; 59(10):1110-7. PubMed ID: 15355471
[TBL] [Abstract][Full Text] [Related]
37. Investigation of the factors that determine the severity of allergic reactions to Hymenoptera venoms.
Soyyigit S; Arslan S; Caliskaner AZ
Allergy Asthma Proc; 2019 Mar; 40(2):116-122. PubMed ID: 30819281
[No Abstract] [Full Text] [Related]
38. Identification, recombinant expression, and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m 5 and Ves v 3.
Blank S; Seismann H; Bockisch B; Braren I; Cifuentes L; McIntyre M; Rühl D; Ring J; Bredehorst R; Ollert MW; Grunwald T; Spillner E
J Immunol; 2010 May; 184(9):5403-13. PubMed ID: 20348419
[TBL] [Abstract][Full Text] [Related]
39. Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects.
Arzt L; Bokanovic D; Schrautzer C; Laipold K; Möbs C; Pfützner W; Herzog SA; Vollmann J; Reider N; Bohle B; Aberer W; Sturm GJ
Allergy; 2018 Jun; 73(6):1223-1231. PubMed ID: 29171032
[TBL] [Abstract][Full Text] [Related]
40. Basal Tryptase Levels Can Predict Clinical Severity in Hymenoptera Venom Anaphylaxis and Ischemic Cardiovascular Disorders.
Farioli L; Losappio LM; Schroeder JW; Preziosi D; Scibilia J; Caron L; Nichelatti M; Pastorello EA
J Investig Allergol Clin Immunol; 2019 Apr; 29(2):162-164. PubMed ID: 31017123
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
